Table 3 Sonographic and clinical factors for IVIG resistance in children with Kawasaki disease
From: Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children
Variables | IVIG response | IVIG resistance | Pvalue | OR (95% CI) |
|---|---|---|---|---|
(n = 47) | (n = 17) | |||
Sonographic factors | ||||
Abnormal GB | 15 (31.9%) | 8 (47.1%) | 0.377 | 1.896 (0.611 ~ 5.887) |
GB distension | 10 (21.3%) | 8 (47.1%) | 0.060 | 3.289 (1.010 ~ 10.715) |
GB wall thickness | 5 (10.6%) | 0 (0%) | 0.313 | 0.894 (0.810 ~ 0.986) |
GB sludge | 0 (0%) | 2 (11.8%) | 0.067 | 1.133 (0.953 ~ 1.348) |
Abnormal liver | 11 (23.9%) | 2 (11.8%) | 0.485 | 0.424 (0.084 ~ 2.151) |
Clinical factors | ||||
Hyperbilirubinemia | 26 (55.3%) | 10 (58.8%) | 1.000 | 1.154 (0.375 ~ 3.551) |
Typical Kawasaki disease | 28(59.6%) | 11(64.7%) | 0.778 | 0.207(0.014 ~ 3.137) |
Fever ≥ 5 days | 43(91.5%) | 16(94.1%) | 1.000 | 0.339(0.012 ~ 9.676) |
Dysmorphous skin rash | 41(87.2%) | 15(88.2%) | 1.000 | 0.647(0.082 ~ 5.093) |
Oral mucosal change | 37(78.7%) | 12(70.6%) | 0.517 | 0.262(0.041 ~ 1.659) |
Conjunctivitis | 41(87.2%) | 13(76.5%) | 0.435 | 0.199(0.023 ~ 1.732) |
Cervical lymphadenopathy | 34(72.3%) | 11(64.7%) | 0.552 | 0.656(0.149 ~ 2.888) |
Peripheral extremity change | 21(44.7%) | 13(76.5%) | 0.045* | 3.579(0.846 ~ 15.136) |